Financial News

Date Title and Summary Additional Formats
Toggle Summary Dartmouth-Hitchcock Health Begins Patient Treatments with ViewRay's MRIdian Linac
Brings Benefits of MRI-Guided Radiation Therapy Closer to Home for Cancer Patients in New England CLEVELAND , Aug. 13, 2020 /PRNewswire/ --  ViewRay, Inc. (Nasdaq: VRAY) announced today that Dartmouth-Hitchcock Health in New Hampshire has begun patient treatments with the MRIdian ® MRI-Guided
Toggle Summary Kaohsiung Medical University Chung-Ho Memorial Hospital Begins Patient Treatments with ViewRay's MRIdian Linac
First MR-Linac in Taiwan Provides Patients Access to MR-Guided Radiation Therapy CLEVELAND , Aug. 5, 2020 /PRNewswire/ --  ViewRay, Inc. (Nasdaq: VRAY) announced today that Kaohsiung Medical University Chung-Ho Memorial Hospital (KMUH) in Kaohsiung City, Taiwan has begun patient treatments with the
Toggle Summary ViewRay Reports Second Quarter 2020 Results
CLEVELAND , July 30, 2020 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) today announced financial results for the second quarter ended June 30, 2020 .     Second Quarter 2020 Highlights: Total revenue of $14.2 million , primarily from two revenue units, compared to $30.2 million , primarily from
Toggle Summary ViewRay Announces Conference Call for Second Quarter 2020 Financial Results to be Held After Market on July 30, 2020
CLEVELAND , July 13, 2020 /PRNewswire/ --   ViewRay, Inc. (Nasdaq: VRAY) announced today details relating to the release of its second quarter 2020 financial results.     ViewRay will hold a conference call to discuss results on Thursday, July 30, 2020 at 4:30 p.m. ET / 1:30 p.m. PT .
Toggle Summary ViewRay Announces 1-Year Outcomes on MR-Guided Radiation Treatment for Prostate Cancer Without Implanted Markers
Study Shows Low Incidence of Toxicity Using Stereotactic Body Radiation Therapy (SBRT) While Reducing Potential Complications Associated with Implanted Markers CLEVELAND , June 23, 2020 /PRNewswire/ --  ViewRay, Inc. (Nasdaq: VRAY) announced today the publication by the European Urology Oncology
Toggle Summary ViewRay Announces Equity Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
CLEVELAND , June 3, 2020 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today grants of stock options and restricted stock units to Zach Stassen , Chief Financial Officer for the company.  These awards were granted as an inducement material to entering into employment with ViewRay , in
Toggle Summary ViewRay® to Present at the Jefferies 2020 Virtual Healthcare Conference
CLEVELAND , May 28, 2020 /PRNewswire/ --  ViewRay, Inc. (NASDAQ: VRAY) announced today that the Company will present at the Jefferies 2020 Virtual Healthcare Conference . Scott Drake , President and CEO, will participate in a fireside chat at 2:30 p.m. Eastern Time on Tuesday, June 2, 2020 .
Toggle Summary Providence Portland Medical Center Begins Patient Treatments with ViewRay's MRIdian Linac
First MR-Linac in the Pacific Northwest Expands Cancer Patients' Access to MR-Guided Radiation Therapy CLEVELAND , May 27, 2020 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today that Providence Portland Medical Center in Portland, Oregon has begun patient treatments with the MRIdian®
Toggle Summary ViewRay Names Zach Stassen as Chief Financial Officer
CLEVELAND , April 30, 2020 /PRNewswire/ --  ViewRay, Inc. (Nasdaq: VRAY) announced today that Zach Stassen has been named Chief Financial Officer, effective May 18, 2020 . Mr. Stassen will report directly to Scott Drake , President and Chief Executive Officer. Mr.
Toggle Summary ViewRay Reports First Quarter 2020 Results
CLEVELAND , April 30, 2020 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) today announced financial results for the first quarter ended March 31, 2020 . First Quarter 2020 Highlights: Total revenue of $14.3 million , primarily from three revenue units including one system upgrade, compared to $20.3
Toggle Summary ViewRay Announces Appointment of B. Kristine Johnson to its Board of Directors
CLEVELAND , April 16, 2020 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced the appointment of B. Kristine Johnson to its Board of Directors effective April 14, 2020 . Ms. Johnson brings a wealth of health care and medical technology knowledge, as well as broad experience in finance and
Toggle Summary ViewRay Announces Conference Call for First Quarter 2020 Financial Results to be Held After Market on April 30, 2020
CLEVELAND , April 9, 2020 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today details relating to the release of its first quarter 2020 financial results. ViewRay will hold a conference call to discuss results on Thursday, April 30, 2020 at 4:30 p.m. ET / 1:30 p.m. PT .
Toggle Summary ViewRay and VieCure Announce Strategic Collaboration to Accelerate Adoption of Personalized Cancer Care
Collaboration offers clinicians a personalized oncology solution that combines cutting-edge MRI-guided radiation therapy with a leading AI-driven EMR integration platform CLEVELAND , April 1, 2020 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today a strategic collaboration with VieCure,
Toggle Summary Enloe Medical Center Becomes First Community Hospital in Northern California to Purchase a MRIdian MRI-Guided Radiation Therapy System
System Order Will Bring the Benefits of MRI-guidance and On-table Adaptive Therapy to Patients Throughout the Region CLEVELAND , March 19, 2020 /PRNewswire/ --  ViewRay, Inc. (Nasdaq: VRAY) announced today that Enloe Medical Center – an independent, nonprofit hospital in Chico , California– has
Toggle Summary Ludwig-Maximilians-University Hospital Begins Patient Treatments with ViewRay's MRIdian Linac
First Treatments at Munich Hospital Leverage MRIdian's Precision for High-Dose Delivery and Adaptive Therapy Capabilities CLEVELAND , March 18, 2020 /PRNewswire/ --  ViewRay, Inc. (Nasdaq: VRAY) announced today that Ludwig-Maximilians-University Hospital in Munich has begun patient treatments with
Toggle Summary ViewRay Reports Fourth Quarter and Full Year 2019 Results
CLEVELAND , March 12, 2020 /PRNewswire/ --  ViewRay, Inc. (Nasdaq: VRAY) today announced financial results for the fourth quarter and full year ended December 31, 2019 . A supplemental presentation for today's conference call is included on the Company's website at
Toggle Summary ViewRay Announces Conference Call and Webcast of Fourth Quarter and Full Year 2019 Financial Results to be Held After Market on March 12, 2020
CLEVELAND , Feb. 13, 2020 /PRNewswire/ --  ViewRay, Inc. (Nasdaq: VRAY) announced today details relating to the release of its fourth quarter and full year 2019 financial results. ViewRay will hold a conference call to discuss results on Thursday, March 12, 2020 at 4:30 p.m. ET / 1:30 p.m. PT .
Toggle Summary ViewRay Announces Preliminary Fourth Quarter and Full Year 2019 Results
CLEVELAND , Jan. 13, 2020 /PRNewswire/ -- ViewRay, Inc. (NASDAQ: VRAY) today announced preliminary results for the fourth quarter and full fiscal year ended December 31, 2019 . The preliminary results have not been audited and are subject to change. Selected Fourth Quarter and Full Year 2019

Stock Quote

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Financial Events
More events are coming soon.

E-mail Alerts

Alerts are e-mailed to you whenever certain new company information is posted to this site. Sign-up Now!
Click here for E-mail Alerts

Transfer Agent
American Stock Transfer & Trust Company, LLC
6201 15th Avenue
Brooklyn, NY 11219
(800) 937-5449
Website: www.amstock.com
Email: info@amstock.com

In Need of Customer Support? Contact

  Language Select